Evaluation of PARP-1 cleavage and caspase-3 cleavage as markers of induction in apoptosis revealed that in gastric cancer cells nab-paclitaxel, oxaliplatin and epirubicin treatment caused an increase in the expression of both cleaved PARP-1 and caspase-3. This evidence concerns the gene PARP1 and gastric cancer.